Jonathan Goodman, MPhil

Researchers sought to evaluate the effects of social support on HRQoL among patients with multiple myeloma or its precursor diseases.

Researchers sought to determine whether maternal occupational exposure to anticancer medications can be linked pediatric leukemia.

Researchers sought to determine whether frontline tazemetostat with R-CHOP maintenance would induce metabolic response in patients with high-risk FL.

Researchers sought to determine whether high-dose cytarabine, with or without vorinostat, is superior to standard cytarabine in previously untreated AML.

Researchers sought to determine whether a 10-day decitabine regimen would have a better safety profile among older patients with AML.

Researchers sought to determine whether combination ibrutinib plus venetoclax would improve survival in patients with previously untreated CLL.

Researchers sought to determine how patients and caregivers rate different factors of clinical care in the iNHL and MM settings.

Researchers sought to determine clinical outcomes among AYAs diagnosed with DLBCL.

Researchers sought to determine the safety and efficacy of combination zanubrutinib plus obinutuzumab in patients with relapsed/refractory FL.

Researchers sought to determine whether adding daratumumab to RVd would improve responses and survival in patients with transplant-eligible multiple myeloma.